Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Inside information: Bioretec adjusts and restates previously reported net sales…
Following the signing of the TSB Distribution Agreement, it became evident that the sales of Bioretec's products in 2025 were not progressing in line with expectations of the TSB Distribution Agreement, and a product repurchase addendum was added on 5 May 2025 to the TSB Distribution Agreement, whereby Bioretec would repurchase from TSB such unpaid products for which TSB was unable to procure purchasers within the payment terms ("Repurchase Addendum"). Following such repurchase under…
PR Newswire
27/10/2025
Syngene International announces plans to add bioconjugation suite for end-to-end…
The OEB-5 rated suite will accelerate ADC development timelines by enabling both Monoclonal Antibodies (mAb) production and GMP bioconjugation at a single site, complementing Syngene's existing commercial capabilities in payload and linker manufacturing. Expected to be operational within this financial year, the conjugation facility will also support a range of advanced conjugates and related modalities. These services are further strengthened by collocated analytical and bioanalytical…
PR Newswire
27/10/2025
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European…
Saint-Herblain (France), October 27 , 2025 –Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe. Valneva will host moderated “fireside chat” presentations to discuss the Company’s key value drivers and upcoming catalysts, primarily the upcoming Phase 3 trial outcomes for...
Nasdaq GlobeNewswire
27/10/2025
Global Optogenetics Equipment Market Valued at USD 400 Million in 2024…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1067180 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1067180 202 - Pages126 – Tables37 – Figures Scope Of The Report Feed Antioxidants Market Overview 1. Rising Global Adoption of Optogenetic Technologies The Optogenetics Equipment Market is witnessing widespread adoption across neuroscience and biomedical research sectors. Researchers are...
PR Newswire
27/10/2025
Tendon Repair Market to Reach $2.8 Billion by 2027 in the short term and $4.1…
Request Sample of the Report on Tendon Repair Market Forecast 2034 – https://www.alliedmarketresearch.com/request-sample/A17088 Request Sample of the Report on Tendon Repair Market Forecast 2034 –https://www.alliedmarketresearch.com/request-sample/A17088 Market Introduction The tendon repair market focuses on the development and commercialization of surgical and non-surgical treatments aimed at restoring tendon function after injury or degeneration. Tendon injuries are common...
PR Newswire
27/10/2025
Global Ovulation Test Market Driven by Rising Fertility Awareness, Technological…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=306139 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=306139 202 – Pages 126 – Tables 37 – Figures Scope Of The Report Feed Antioxidants Market Overview 1. Market Definition and ScopeThe Ovulation Test Market encompasses products designed to help women detect fertile periods by measuring hormone levels, primarily luteinizing hormone (LH), in urine...
PR Newswire
27/10/2025
Japan Anti-Aging Product Market Set to Reach USD 6.15 Billion by 2033 as Premium…
Browse in-depth TOC on "Japan Anti-Aging Products Market" 76 – Tables69 – Figures189 – Pages Browse in-depth TOC on "Japan Anti-Aging Products Market"76 – Tables 69 – Figures 189 – Pages Market Segmentation: Product Type, Age Group, Gender & Channel Within the Japanese anti-aging sector, growth dynamics are manifest across multiple segmentation axes. ByProduct Type, the market coversSkincare(including moisturizers, serums and concentrates, eye care, cleansers &...
PR Newswire
27/10/2025
The WEMP Foundation and Rafa Nadal Foundation are joining together to Support…
Dr. Adrian Cheng has invited Rafael Nadalas a co-host of The Children Ball 2025. The two began their partnership with the launch of Asia's first and only Rafa Nadal Tennis Center Hong Kong under Rafa Nadal Academy by Movistar in Hong Kong. Dr. Cheng and Mr. Nadal are deeply committed to the cause, sharing a profound belief that investing in the wellbeing of children is crucial for fostering a brighter future for society. The partnership not only highlights their shared values but also emphasizes…
PR Newswire
27/10/2025
Chromatin Bioscience Announces Collaboration with Purespring Therapeutics
"Purespring's approach to gene therapy aligns well with our mission to provide precise gene control systems that support advanced, tissue-targeted therapeutics," said Michael Roberts, CEO and Founder of Chromatin Bioscience. "We are excited to support their efforts with our platform and help unlock the full therapeutic potential of next-generation gene therapies." "Purespring's approach to gene therapy aligns well with our mission to provide precise gene control systems…
PR Newswire
27/10/2025
Protein Ingredients Market to Reach USD 125.1 Billion by 2031 Amid Rising Demand…
Market Dynamics: From Nutrition to Innovation Market Dynamics: From Nutrition to Innovation The growing global appetite for protein-driven by lifestyle shifts, fitness trends, and population growth-is propelling innovations in bothplant-basedandanimal-derivedprotein ingredients. Key growth drivers include: Download PDF Brochure:https://www.datamintelligence.com/download-sample/protein-ingredients-market Browse in-depth TOC on "Protein Ingredients Market" ...
PR Newswire
27/10/2025
/C O R R E C T I O N -- SheMed/
LONDON, Oct. 23, 2025 /PRNewswire/ -- SheMed, the female-founded health technology company changing how women access personalised healthcare, today announced it has raised $50 million at a $1bn valuation to further develop its innovative health platform and advance new breakthroughs for preemptive healthcare. LONDON , Oct. 23, 2025 /PRNewswire/ -- SheMed , the female-founded health technology company changing how women access personalised healthcare, today announced it has raised$50...
PR Newswire
27/10/2025
Queen Square Imaging Centre: New technique could improve outcomes for essential…
Now, a new technique using FAT1 imaging - a sophisticated MRI approach that fuses multiple scan types - is offering hope to patients. Now, a new technique using FAT1 imaging - a sophisticated MRI approach that fuses multiple scan types - is offering hope to patients. A study inBMJ Neurology Openstudy reports the first use of FAT1 imaging to guide focused ultrasound for essential tremor. Traditionally, clinicians have relied on generalised brain maps to estimate the location of the target...
PR Newswire
27/10/2025
Philips introduces industry-first cath lab integration that automatically…
October 27, 2025 New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and additional anatomical insights in PCI procedures 1 San Francisco, USA and Amsterdam, The Netherlands –At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting,Royal Philips(NYSE: PHG, AEX: PHIA),...
Nasdaq GlobeNewswire
27/10/2025
Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program
"This End-of-Phase 2 meeting is a crucial milestone for our refractory gout program" says Dr. Bing Li, Shanton's CEO, "as it provides alignment with FDA on our upcoming Phase 3 pivotal program, including protocol, trial design, patient population, dose selection, proposed endpoints, and statistical analysis methods. Based on FDA's feedback we are confident to enter into a Multi-Regional Clinical Trial program in the coming months, aiming to offer a much-needed solution for…
PR Newswire
27/10/2025
Curia Invests $4 Million to Enhance Sterile API Manufacturing
The enhancements support upgrades to Valladolid’s infrastructure and technology. Curia used innovative tools to take advantage of new possibilities derived from the application of an enhanced process understanding. The bulk of the investment was dedicated to updating the site’s equipment, including the installation of new isolators, along with modernizations to HVAC, pharmaceutical panels, automation, sterilization in place and general utilities. Transitioning to a fully closed system was...
Nasdaq GlobeNewswire
27/10/2025
Kolmar Korea Selected for Government-Led 'AI Factory' Initiative -- Driving…
The Ministry of Trade, Industry and Resources (MOTIR) is South Korea's central government agency overseeing industrial technology, R&D, commerce, and trade. Under its national vision of becoming the "World's Leading Manufacturing Power by 2030," the ministry launched the AI Factory M.AX (AI Transformation) Alliance, selecting leading companies from each sector to drive AI innovation in manufacturing. Kolmar Korea was chosen as the sole cosmetics company to lead the initiative…
PR Newswire
27/10/2025
Building a Greener Future: 138th Canton Fair Marks the Rise of Eco-Friendly…
Another exhibitor, led by its general manager, has participated in over 40 editions of the fair and maintains a presence in more than 50 countries. The company continues to view the Canton Fair as a strategic gateway to global markets. Its featured offerings include wall panels made from medical-grade PVC and bamboo fiber, designed for moisture resistance, mold prevention, and easy installation. The exhibitor also introduced WPC outdoor flooring, combining the natural appearance of wood with the…
PR Newswire
27/10/2025
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability…
Click here to view the custom infographic of the Oncotelic Therapeutics editorial. Clickhere to view the custom infographic of the Oncotelic Therapeutics editorial. The Global Shift Toward Smarter Drug Delivery The pharmaceutical industry is entering an inflection point driven by therecognition that highly potent cancer drugs are only as effective as their ability to reach tumors with sufficient concentration. Many promising oncology drugs fail not because the therapy lacks...
PR Newswire
27/10/2025
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer
Dr Tayton-Martin brings broad experience of biotech company building, fund-raising, M&A, business development and operations with a strong track record of strategic partnership dealsHer more than 30 years of experience include leadership roles in the UK and US, from early research through to product approval in cancer immunotherapy, making her the ideal candidate to lead the next stage of execution of Evaxion’s strategy Birgitte Rønø, who has served as interim Chief Executive...
Nasdaq GlobeNewswire
27/10/2025
KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in…
The new plant, located on the hospital’s Riyadh campus, will produce CAR T-cell and stem-cell therapies, treatments that re-engineer a patient’s own cells to fight cancer or repair damaged tissue. Spanning more than 5,000 square meters, the facility is designed around 16 modular clean-room clusters that can expand or adapt as new therapeutic technologies evolve.Officials said the complex marks a milestone in Saudi Arabia’s biotechnology ambitions, bringing precision medicine and advanced...
Nasdaq GlobeNewswire
27/10/2025
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on…
MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE)--BioNTech SE(Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2025 on Monday, November 3, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EST (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.To access the live conference call via telephone, please...
Nasdaq GlobeNewswire
27/10/2025
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on…
MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE)--BioNTech SE(Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2025 on Monday, November 3, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EST (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.To access the live conference call via telephone, please...
Nasdaq GlobeNewswire
27/10/2025
Immatics Appoints Amie Krause as Chief People Officer
Houston , Texas and Tuebingen, Germany, October 27, 2025–Immatics N.V.(NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today announced the appointment of Amie Krause as Chief People Officer (“CPO”) effective October 27, 2025. Ms. Krause brings more than 20 years of experience in shaping culture, leading organizational growth and aligning talent with business strategy, including across global...
Nasdaq GlobeNewswire
27/10/2025
Antibody-Drug Conjugates Market to Surge to US $30.42 Billion by 2033, Fueled by…
Download PDF Brochure: https://www.datamintelligence.com/download-sample/antibody-drug-conjugates-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/antibody-drug-conjugates-market Browse in-depth TOC on "Antibody-Drug Conjugates Market"70 – Tables 66 – Figures 195 – Pages Market Outlook: Accelerated Growth in Oncology's Most Promising Segment In 2024, the Antibody-Drug Conjugates market crossed the US$11 billionthreshold, propelled by...
PR Newswire
27/10/2025
Altri Comunicati
